Entrada Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $110k | 19k | 5.80 |
| 2025-06-30 | $166k | 25k | 6.72 |
| 2025-03-31 | $461k | 51k | 9.04 |
| 2024-12-31 | $918k | 53k | 17.29 |
| 2024-09-30 | $399k | 25k | 15.98 |
| 2024-06-30 | $311k | 22k | 14.25 |
| 2024-03-31 | $333k | 24k | 14.17 |
| 2023-12-31 | $339k | 23k | 15.09 |
| 2023-09-30 | $210k | 13k | 15.80 |
| 2023-06-30 | $207k | 14k | 15.14 |
| 2023-03-31 | $21k | 1.5k | 14.50 |
| 2022-12-31 | $17k | 1.3k | 13.52 |
| 2022-06-30 | $11k | 597 | 18.87 |
| 2022-03-31 | $11k | 1.4k | 7.75 |
| 2021-12-31 | $48k | 2.8k | 17.06 |